What is NCT00046527, and what is the Abraxane (albumin-bound paclitaxel) objective response rate?
NCT00046527 is a clinical trial record in ClinicalTrials.gov for testing Abraxane (albumin-bound paclitaxel). The objective response rate (ORR) reported for a trial is the proportion of patients whose tumors shrink by a prespecified amount and for a minimum duration based on the trial’s response criteria (commonly RECIST).
However, the objective response rate value itself is not included in the information provided here, so I can’t state the ORR for NCT00046527 without the trial’s results section (or the specific publication that reports ORR).
If you paste the “Results” text from the NCT00046527 page (or tell me which cancer type/arm you mean), I can extract the exact ORR numbers and summarize them cleanly.
Which study arms/disease types does NCT00046527 cover (and which ORR applies)?
Objective response rate can differ by:
- cancer indication (e.g., metastatic breast cancer, pancreatic cancer, etc.)
- dose level or schedule
- treatment line (first-line vs later-line)
- evaluable population (intent-to-treat vs response-evaluable patients)
NCT identifiers can include multiple cohorts or arms, so the ORR you want depends on the exact arm.
Are you looking for ORR by RECIST or another response definition?
Clinical trials may report ORR using RECIST or similar criteria, sometimes with separate reporting for:
- “confirmed” responses vs best overall response
- measurable disease only vs broader criteria
- central review vs investigator assessment
The ORR number can change depending on the response definition used.
If you want, I can look up the ORR—what details should you provide?
To give you the exact Abraxane objective response rate for NCT00046527, send one of the following:
- the ORR sentence/paragraph from the NCT00046527 results section, or
- the trial results PDF/publication title and the cancer type/arm you care about, or
- a screenshot or copied table rows that include ORR
Sources: none provided in your message (no trial results text or link was included).